1 Fabry Disease Therapeutic Introduction and Market Overview 1.1 Objectives of the Study 1.2 Definition of Fabry Disease Therapeutic 1.3 Fabry Disease Therapeutic Market Scope and Market Size Estimation 1.3.1 Market Concentration Ratio and Market Maturity Analysis 1.3.2 Europe Fabry Disease Therapeutic Value and Growth Rate from 2014-2024 1.4 Market Segmentation 1.4.1 Types of Fabry Disease Therapeutic 1.4.2 Applications of Fabry Disease Therapeutic 1.4.3 Research Countries 1.5 Market Dynamics 1.5.1 Drivers 1.5.2 Limitations 1.5.3 Opportunities 1.6 Industry News and Policies by Countries 1.6.1 Industry News 1.6.2 Industry Policies 2 Industry Chain Analysis 2.1 Upstream Raw Material Suppliers of Fabry Disease Therapeutic Analysis 2.2 Major Players of Fabry Disease Therapeutic 2.2.1 Major Players Manufacturing Base and Market Share of Fabry Disease Therapeutic in 2018 2.2.2 Major Players Product Types in 2018 2.3 Fabry Disease Therapeutic Manufacturing Cost Structure Analysis 2.3.1 Consumption Process Analysis 2.3.2 Manufacturing Cost Structure of Fabry Disease Therapeutic 2.3.3 Raw Material Cost of Fabry Disease Therapeutic 2.3.4 Labor Cost of Fabry Disease Therapeutic 2.4 Market Channel Analysis of Fabry Disease Therapeutic 2.5 Major Downstream Buyers of Fabry Disease Therapeutic Analysis 3 Europe Fabry Disease Therapeutic Market, by Type 3.1 Europe Fabry Disease Therapeutic Value and Market Share by Type (2014-2019E) 3.2 Europe Fabry Disease Therapeutic Consumption and Market Share by Type (2014-2019E) 3.3 Europe Fabry Disease Therapeutic Value and Growth Rate by Type (2014-2019E) 3.3.1 Europe Fabry Disease Therapeutic Value and Growth Rate of Enzyme Replacement Therapy 3.3.2 Europe Fabry Disease Therapeutic Value and Growth Rate of Alternative therapies 3.4 Europe Fabry Disease Therapeutic Price Analysis by Type (2014-2019E) 4 Fabry Disease Therapeutic Market, by Application 4.1 Downstream Market Overview 4.2 Europe Fabry Disease Therapeutic Consumption and Market Share by Application (2014-2019E) 4.2.1 Europe Fabry Disease Therapeutic Consumption and Growth Rate of Hospitals (2014-2019E) 4.2.2 Europe Fabry Disease Therapeutic Consumption and Growth Rate of Clinics (2014-2019E) 4.2.3 Europe Fabry Disease Therapeutic Consumption and Growth Rate of Others (2014-2019E) 5 Europe Fabry Disease Therapeutic Consumption, Value ($) by Countries (2014-2019E) 5.1 Europe Fabry Disease Therapeutic Value and Market Share by Countries (2014-2019E) 5.2 Europe Fabry Disease Therapeutic Consumption and Market Share by Countries (2014-2019E) 5.3 Europe Fabry Disease Therapeutic Consumption, Value, Price and Gross Margin (2014-2019E) 5.4 Germany Fabry Disease Therapeutic Consumption, Value, Price and Gross Margin (2014-2019E) 5.5 UK Fabry Disease Therapeutic Consumption, Value, Price and Gross Margin (2014-2019E) 5.6 France Fabry Disease Therapeutic Consumption, Value, Price and Gross Margin (2014-2019E) 5.7 Italy Fabry Disease Therapeutic Consumption, Value, Price and Gross Margin (2014-2019E) 5.8 Spain Fabry Disease Therapeutic Consumption, Value, Price and Gross Margin (2014-2019E) 5.9 Russia Fabry Disease Therapeutic Consumption, Value, Price and Gross Margin (2014-2019E) 6 Competitive Landscape 6.1 Competitive Profile 6.2 Sanofi-Aventis LLC 6.2.1 Company Profiles 6.2.2 Fabry Disease Therapeutic Product Introduction 6.2.3 Sanofi-Aventis LLC Sales, Value, Price, Gross Margin 2014-2019E 6.2.4 Sanofi-Aventis LLC Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 6.3 Green Cross Corp. 6.3.1 Company Profiles 6.3.2 Fabry Disease Therapeutic Product Introduction 6.3.3 Green Cross Corp. Sales, Value, Price, Gross Margin 2014-2019E 6.3.4 Green Cross Corp. Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 6.4 Bristol-Myers Squibb Company 6.4.1 Company Profiles 6.4.2 Fabry Disease Therapeutic Product Introduction 6.4.3 Bristol-Myers Squibb Company Sales, Value, Price, Gross Margin 2014-2019E 6.4.4 Bristol-Myers Squibb Company Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 6.5 AbbVie Inc. 6.5.1 Company Profiles 6.5.2 Fabry Disease Therapeutic Product Introduction 6.5.3 AbbVie Inc. Sales, Value, Price, Gross Margin 2014-2019E 6.5.4 AbbVie Inc. Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 6.6 Genzyme-Sanofi 6.6.1 Company Profiles 6.6.2 Fabry Disease Therapeutic Product Introduction 6.6.3 Genzyme-Sanofi Sales, Value, Price, Gross Margin 2014-2019E 6.6.4 Genzyme-Sanofi Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 6.7 Shire 6.7.1 Company Profiles 6.7.2 Fabry Disease Therapeutic Product Introduction 6.7.3 Shire Sales, Value, Price, Gross Margin 2014-2019E 6.7.4 Shire Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 6.8 Amicus therapeutics 6.8.1 Company Profiles 6.8.2 Fabry Disease Therapeutic Product Introduction 6.8.3 Amicus therapeutics Sales, Value, Price, Gross Margin 2014-2019E 6.8.4 Amicus therapeutics Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 6.9 Amgen Inc. 6.9.1 Company Profiles 6.9.2 Fabry Disease Therapeutic Product Introduction 6.9.3 Amgen Inc. Sales, Value, Price, Gross Margin 2014-2019E 6.9.4 Amgen Inc. Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 6.10 Novartis Pharmaceuticals 6.10.1 Company Profiles 6.10.2 Fabry Disease Therapeutic Product Introduction 6.10.3 Novartis Pharmaceuticals Sales, Value, Price, Gross Margin 2014-2019E 6.10.4 Novartis Pharmaceuticals Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 6.11 Takeda Pharmaceutical Co. Ltd. 6.11.1 Company Profiles 6.11.2 Fabry Disease Therapeutic Product Introduction 6.11.3 Takeda Pharmaceutical Co. Ltd. Sales, Value, Price, Gross Margin 2014-2019E 6.11.4 Takeda Pharmaceutical Co. Ltd. Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 6.12 GlaxoSmithKline plc 6.12.1 Company Profiles 6.12.2 Fabry Disease Therapeutic Product Introduction 6.12.3 GlaxoSmithKline plc Sales, Value, Price, Gross Margin 2014-2019E 6.12.4 GlaxoSmithKline plc Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 6.13 Protalix 6.13.1 Company Profiles 6.13.2 Fabry Disease Therapeutic Product Introduction 6.13.3 Protalix Sales, Value, Price, Gross Margin 2014-2019E 6.13.4 Protalix Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 6.14 Teva pharmaceutical Industries Ltd. 6.14.1 Company Profiles 6.14.2 Fabry Disease Therapeutic Product Introduction 6.14.3 Teva pharmaceutical Industries Ltd. Sales, Value, Price, Gross Margin 2014-2019E 6.14.4 Teva pharmaceutical Industries Ltd. Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 6.15 Pfizer 6.15.1 Company Profiles 6.15.2 Fabry Disease Therapeutic Product Introduction 6.15.3 Pfizer Sales, Value, Price, Gross Margin 2014-2019E 6.15.4 Pfizer Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 6.16 Merck & Co. 6.16.1 Company Profiles 6.16.2 Fabry Disease Therapeutic Product Introduction 6.16.3 Merck & Co. Sales, Value, Price, Gross Margin 2014-2019E 6.16.4 Merck & Co. Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 7 Europe Fabry Disease Therapeutic Market Analysis and Forecast by Type and Application 7.1 Europe Fabry Disease Therapeutic Market Value & Volume Forecast, by Type (2019-2024) 7.1.1 Enzyme Replacement Therapy Market Value and Volume Forecast (2019-2024) 7.1.2 Alternative therapies Market Value and Volume Forecast (2019-2024) 7.2 Europe Fabry Disease Therapeutic Market Value & Volume Forecast, by Application (2019-2024) 7.2.1 Hospitals Market Value and Volume Forecast (2019-2024) 7.2.2 Clinics Market Value and Volume Forecast (2019-2024) 7.2.3 Others Market Value and Volume Forecast (2019-2024) 8 Fabry Disease Therapeutic Market Analysis and Forecast by Countries 8.1 Germany Market Value and Consumption Forecast (2019-2024) 8.2 UK Market Value and Consumption Forecast (2019-2024) 8.3 France Market Value and Consumption Forecast (2019-2024) 8.4 Italy Market Value and Consumption Forecast (2019-2024) 8.5 Spain Market Value and Consumption Forecast (2019-2024) 8.6 Russia Market Value and Consumption Forecast (2019-2024) 9 New Project Feasibility Analysis 9.1 Industry Barriers and New Entrants SWOT Analysis 9.2 Analysis and Suggestions on New Project Investment 10 Research Finding and Conclusion 11 Appendix 11.1 Methodology 11.2 Research Data Source

List of Tables and Figures Figure Product Picture of Fabry Disease Therapeutic Table Product Specification of Fabry Disease Therapeutic Figure Market Concentration Ratio and Market Maturity Analysis of Fabry Disease Therapeutic Figure Europe Fabry Disease Therapeutic Value ($) and Growth Rate from 2014-2024 Table Different Types of Fabry Disease Therapeutic Figure Europe Fabry Disease Therapeutic Value ($) Segment by Type from 2014-2019E Figure Europe Fabry Disease Therapeutic Market Share by Types in 2018 Figure Enzyme Replacement Therapy Picture Figure Alternative therapies Picture Table Different Applications of Fabry Disease Therapeutic Figure Europe Fabry Disease Therapeutic Value ($) Segment by Applications from 2014-2019E Figure Europe Fabry Disease Therapeutic Market Share by Applications in 2018 Figure Hospitals Picture Figure Clinics Picture Figure Others Picture Table Research Countries of Fabry Disease Therapeutic Figure Europe Fabry Disease Therapeutic Market Share by Countries in 2018 Figure Germany Fabry Disease Therapeutic Consumption Value ($) and Growth Rate (2014-2019E) Figure UK Fabry Disease Therapeutic Consumption Value ($) and Growth Rate (2014-2019E) Figure France Fabry Disease Therapeutic Consumption Value ($) and Growth Rate (2014-2019E) Figure Italy Fabry Disease Therapeutic Consumption Value ($) and Growth Rate (2014-2019E) Figure Spain Fabry Disease Therapeutic Consumption Value ($) and Growth Rate (2014-2019E) Figure Russia Fabry Disease Therapeutic Consumption Value ($) and Growth Rate (2014-2019E) Table Emerging and Growing Market of Fabry Disease Therapeutic Table Industry News Table Industry Policies Figure Industry Chain Analysis of Fabry Disease Therapeutic Table Upstream Raw Material Suppliers of Fabry Disease Therapeutic with Contact Information Table Major Players Manufacturing Base and Market Share of Fabry Disease Therapeutic in 2018 Table Major Players Consumption Value Market Share of Fabry Disease Therapeutic in 2018 Table Major Players Fabry Disease Therapeutic Product Types in 2018 Figure Consumption Process of Fabry Disease Therapeutic Figure Manufacturing Cost Structure of Fabry Disease Therapeutic Figure Channel Status of Fabry Disease Therapeutic Table Major Distributors of Fabry Disease Therapeutic with Contact Information Table Major Downstream Buyers of Fabry Disease Therapeutic with Contact Information Table Europe Fabry Disease Therapeutic Value ($) by Type (2014-2019E) Table Europe Fabry Disease Therapeutic Value Share by Type (2014-2019E) Figure Europe Fabry Disease Therapeutic Value Share by Type (2014-2019E) Table Europe Fabry Disease Therapeutic Consumption by Type (2014-2019E) Table Europe Fabry Disease Therapeutic Consumption Share by Type (2014-2019E) Figure Europe Fabry Disease Therapeutic Consumption Share by Type (2014-2019E) Figure Enzyme Replacement Therapy Picture Figure Alternative therapies Picture Figure Europe Fabry Disease Therapeutic Value ($) and Growth Rate of Alternative therapies Table Europe Fabry Disease Therapeutic Price by Type (2014-2019E) Figure Downstream Market Overview Table Europe Fabry Disease Therapeutic Consumption by Application (2014-2019E) Table Europe Fabry Disease Therapeutic Consumption Market Share by Application (2014-2019E) Figure Europe Fabry Disease Therapeutic Consumption Market Share by Application (2014-2019E) Figure Europe Fabry Disease Therapeutic Consumption and Growth Rate of Hospitals (2014-2019) Figure Europe Fabry Disease Therapeutic Consumption and Growth Rate of Clinics (2014-2019) Figure Europe Fabry Disease Therapeutic Consumption and Growth Rate of Others (2014-2019) Table Europe Fabry Disease Therapeutic Value ($) by Countries (2014-2019E) Table Europe Fabry Disease Therapeutic Value Market Share by Countries (2014-2019E) Figure Europe Fabry Disease Therapeutic Value Market Share by Countries (2014-2019E) Table Europe Fabry Disease Therapeutic Consumption by Countries (2014-2019E) Table Europe Fabry Disease Therapeutic Consumption Market Share by Countries (2014-2019E) Figure Europe Fabry Disease Therapeutic Consumption Market Share by Countries (2014-2019E) Table Europe Fabry Disease Therapeutic Consumption, Value, Price and Gross Margin (2014-2019E) Table Germany Fabry Disease Therapeutic Consumption, Value, Price and Gross Margin (2014-2019E) Table UK Fabry Disease Therapeutic Consumption, Value, Price and Gross Margin (2014-2019E) Table France Fabry Disease Therapeutic Consumption, Value, Price and Gross Margin (2014-2019E) Table Italy Fabry Disease Therapeutic Consumption, Value, Price and Gross Margin (2014-2019E) Table Spain Fabry Disease Therapeutic Consumption, Value, Price and Gross Margin (2014-2019E) Table Russia Fabry Disease Therapeutic Consumption, Value, Price and Gross Margin (2014-2019E) Figure Top 3 Market Share of Fabry Disease Therapeutic Companies in 2018 Figure Top 6 Market Share of Fabry Disease Therapeutic Companies in 2018 Table Major Players Value ($) Share (2014-2019E) Table Company Profiles Table Product Introduction Table Sanofi-Aventis LLC Sales, Value, Price, Gross Margin 2014-2019E Figure Sanofi-Aventis LLC Sales and Growth Rate Figure Sanofi-Aventis LLC Value ($) Market Share 2014-2019 Figure Sanofi-Aventis LLC Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Green Cross Corp. Sales, Value, Price, Gross Margin 2014-2019E Figure Green Cross Corp. Sales and Growth Rate Figure Green Cross Corp. Value ($) Market Share 2014-2019 Figure Green Cross Corp. Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Bristol-Myers Squibb Company Sales, Value, Price, Gross Margin 2014-2019E Figure Bristol-Myers Squibb Company Sales and Growth Rate Figure Bristol-Myers Squibb Company Value ($) Market Share 2014-2019 Figure Bristol-Myers Squibb Company Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table AbbVie Inc. Sales, Value, Price, Gross Margin 2014-2019E Figure AbbVie Inc. Sales and Growth Rate Figure AbbVie Inc. Value ($) Market Share 2014-2019 Figure AbbVie Inc. Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Genzyme-Sanofi Sales, Value, Price, Gross Margin 2014-2019E Figure Genzyme-Sanofi Sales and Growth Rate Figure Genzyme-Sanofi Value ($) Market Share 2014-2019 Figure Genzyme-Sanofi Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Shire Sales, Value, Price, Gross Margin 2014-2019E Figure Shire Sales and Growth Rate Figure Shire Value ($) Market Share 2014-2019 Figure Shire Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Amicus therapeutics Sales, Value, Price, Gross Margin 2014-2019E Figure Amicus therapeutics Sales and Growth Rate Figure Amicus therapeutics Value ($) Market Share 2014-2019 Figure Amicus therapeutics Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Amgen Inc. Sales, Value, Price, Gross Margin 2014-2019E Figure Amgen Inc. Sales and Growth Rate Figure Amgen Inc. Value ($) Market Share 2014-2019 Figure Amgen Inc. Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Novartis Pharmaceuticals Sales, Value, Price, Gross Margin 2014-2019E Figure Novartis Pharmaceuticals Sales and Growth Rate Figure Novartis Pharmaceuticals Value ($) Market Share 2014-2019 Figure Novartis Pharmaceuticals Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Takeda Pharmaceutical Co. Ltd. Sales, Value, Price, Gross Margin 2014-2019E Figure Takeda Pharmaceutical Co. Ltd. Sales and Growth Rate Figure Takeda Pharmaceutical Co. Ltd. Value ($) Market Share 2014-2019 Figure Takeda Pharmaceutical Co. Ltd. Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table GlaxoSmithKline plc Sales, Value, Price, Gross Margin 2014-2019E Figure GlaxoSmithKline plc Sales and Growth Rate Figure GlaxoSmithKline plc Value ($) Market Share 2014-2019 Figure GlaxoSmithKline plc Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Protalix Sales, Value, Price, Gross Margin 2014-2019E Figure Protalix Sales and Growth Rate Figure Protalix Value ($) Market Share 2014-2019 Figure Protalix Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Teva pharmaceutical Industries Ltd. Sales, Value, Price, Gross Margin 2014-2019E Figure Teva pharmaceutical Industries Ltd. Sales and Growth Rate Figure Teva pharmaceutical Industries Ltd. Value ($) Market Share 2014-2019 Figure Teva pharmaceutical Industries Ltd. Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Pfizer Sales, Value, Price, Gross Margin 2014-2019E Figure Pfizer Sales and Growth Rate Figure Pfizer Value ($) Market Share 2014-2019 Figure Pfizer Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Merck & Co. Sales, Value, Price, Gross Margin 2014-2019E Figure Merck & Co. Sales and Growth Rate Figure Merck & Co. Value ($) Market Share 2014-2019 Figure Merck & Co. Market Share of Fabry Disease Therapeutic Segmented by Region in 2018 Table Europe Fabry Disease Therapeutic Market Value ($) Forecast, by Type Table Europe Fabry Disease Therapeutic Market Volume Forecast, by Type Table Europe Market Value ($) Forecast by Application (2019-2024) Table Europe Market Volume Forecast by Application (2019-2024) Figure Germany Market Value ($) and Growth Rate Forecast (2019-2024) Figure Germany Consumption and Growth Rate Forecast (2019-2024) Figure UK Market Value ($) and Growth Rate Forecast (2019-2024) Figure UK Consumption and Growth Rate Forecast (2019-2024) Figure France Market Value ($) and Growth Rate Forecast (2019-2024) Figure France Consumption and Growth Rate Forecast (2019-2024) Figure Italy Market Value ($) and Growth Rate Forecast (2019-2024) Figure Italy Consumption and Growth Rate Forecast (2019-2024) Figure Spain Market Value ($) and Growth Rate Forecast (2019-2024) Figure Spain Consumption and Growth Rate Forecast (2019-2024) Figure Russia Market Value ($) and Growth Rate Forecast (2019-2024) Figure Russia Consumption and Growth Rate Forecast (2019-2024) Figure Industry Resource/Technology/Labor Importance Analysis Table New Entrants SWOT Analysis Table New Project Analysis of Investment Recovery